Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Nov 18, 2026, 4:00 PM EST
1.015
-0.015 (-1.48%)
Pre-market: Nov 19, 2026, 4:40 AM EST
Cellectis Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Cellectis stock has a consensus rating of "Buy" and an average price target of $4.45. The average 1-year stock price forecast is 332.04% higher than the current stock price, while the lowest is $1.30 (+26.21%) and the highest is $8.00 (+676.70%).
Price Target: $4.45 (+332.04%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cellectis stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $1.3 | Sell | Maintains | $1.3 | +26.21% | Nov 17, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +676.70% | Sep 15, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $4 → $3 | Hold | Reiterates | $4 → $3 | +191.26% | Sep 15, 2026 |
| Citizens JMP | Citizens JMP | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Sep 15, 2026 |
Financial Forecast
Revenue This Year
64.86M
from 79.59M
Decreased by -18.51%
Revenue Next Year
50.01M
from 64.86M
Decreased by -22.89%
EPS This Year
-0.86
from -0.61
EPS Next Year
-1.81
from -0.86
EPS and Forward PE are based on non-GAAP adjusted numbers.